Evidence map›Paper›PMID 34796363›Full record

ArticleInternational journal of transgender health2021

Pregnancy intentions and outcomes among transgender, nonbinary, and gender-expansive people assigned female or intersex at birth in the United States: Results from a national, quantitative survey.

Heidi Moseson, Laura Fix, Jen Hastings, Ari Stoeffler, Mitchell R Lunn, Annesa Flentje, Micah E Lubensky, Matthew R Capriotti, Sachiko Ragosta, Hannah Forsberg and 1 more

2 registry-linked trialsOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of transgender health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06450405 phase4terminatednot on this mapstarted 2025, after this paper: background citation

Androgen Effects on the Reproductive Neuroendocrine Axis

TypeinterventionalSponsorUniversity of California, San DiegoRan2025 to 2025Enrolled2ConditionsTransgenderism, Reproductive IssuesArmsTestosterone Cypionate 50 MG/ML Injectable Solution
NCT07092527 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version

TypeinterventionalSponsorUniversity of California, San DiegoRan2025 to 2028Enrolled80ConditionsTransgenderism, Reproductive IssuesArmsTestosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. U.S. Selected Practice Recommendations for Contraceptive Use, 2024.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2024
    Guideline
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Transgender Youth's Perspectives on the Relationships Between Pregnancy, Contraceptives, and Dysphoria.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pregnancy episodes in All of Us: harnessing multi-source data for pregnancy-related research.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Heidi MosesonIbis Reproductive Health, Oakland, California, USA.ORCID https://orcid.org/0000-0002-2488-2429
Laura FixIbis Reproductive Health, Cambridge, Massachusetts, USA.
Jen HastingsDepartment of Family and Community Medicine, University of California, San Francisco, California, USA.
Ari StoefflerPlanned Parenthood of Massachusetts, Boston, Massachusetts, USA.
Mitchell R LunnDivision of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.ORCID https://orcid.org/0000-0002-0068-0814
Annesa FlentjeDepartment of Community Health Systems, University of California, San Francisco, California, USA.
Micah E LubenskyThe PRIDE Study/PRIDEnet, Stanford University, Stanford, California, USA.ORCID https://orcid.org/0000-0001-8882-0967
Matthew R CapriottiThe PRIDE Study/PRIDEnet, Stanford University, Stanford, California, USA.
Sachiko RagostaIbis Reproductive Health, Oakland, California, USA.
Hannah ForsbergIbis Reproductive Health, Oakland, California, USA.
Juno Obedin-MaliverThe PRIDE Study/PRIDEnet, Stanford University, Stanford, California, USA.ORCID https://orcid.org/0000-0002-0945-2842
Ibis Reproductive Health · USPride Foundation · USUniversity of California, San Francisco · USPlanned Parenthood · US

Funding

UCSF-Kaiser Urological Epidemiology Research Career Development ProgramK12DK111028 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, ALISON · 2016 to 2025
$5.3M
Gene expression outcomes in interventions for substance using HIV+ minority menK23DA039800 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FLENTJE, ANNESA · 2015 to 2019
$1.0M
NIDA NIH HHS K23 DA039800NIDDK NIH HHS K12 DK111028
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

abortionbirthintersexmiscarriagenonbinarypregnancytestosteronetransgender

Identifiers

PMID34796363
PMCPMC8040680
OpenAlexW3105452769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.